|
アリイズミ シユンイチ
ARIIZUMI Shunichi
有泉 俊一 所属 医学部 医学科（東京女子医科大学病院） 職種 准教授 |
|
| 論文種別 | 原著 |
| 言語種別 | 英語 |
| 査読の有無 | 査読なし |
| 表題 | Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. |
| 掲載誌名 | 正式名：Journal of hepatology 略 称：J Hepatol ISSNコード：16000641/01688278 |
| 掲載区分 | 国外 |
| 巻・号・頁 | 68(5),pp.959-969 |
| 著者・共著者 | Wardell Christopher P, Fujita Masashi, Yamada Toru, Simbolo Michele, Fassan Matteo, Karlic Rosa, Polak Paz, Kim Jaegil, Hatanaka Yutaka, Maejima Kazuhiro, Lawlor Rita T, Nakanishi Yoshitsugu, Mitsuhashi Tomoko, Fujimoto Akihiro, Furuta Mayuko, Ruzzenente Andrea, Conci Simone, Oosawa Ayako, Sasaki-Oku Aya, Nakano Kaoru, Tanaka Hiroko, Yamamoto Yujiro, Michiaki Kubo, Kawakami Yoshiiku, Aikata Hiroshi, Ueno Masaki, Hayami Shinya, Gotoh Kunihito, Ariizumi Shun-Ichi, Yamamoto Masakazu, Yamaue Hiroki, Chayama Kazuaki, Miyano Satoru, Getz Gad, Scarpa Aldo, Hirano Satoshi, Nakamura Toru, Nakagawa Hidewaki |
| 発行年月 | 2018/05 |
| 概要 | BACKGROUND & AIMS:Biliary tract cancers (BTCs) are clinically and pathologically heterogeneous and respond poorly to treatment. Genomic profiling can offer a clearer understanding of their carcinogenesis, classification and treatment strategy. We performed large-scale genome sequencing analyses on BTCs to investigate their somatic and germline driver events and characterize their genomic landscape.METHODS:We analyzed 412 BTC samples from Japanese and Italian populations, 107 by whole-exome sequencing (WES), 39 by whole-genome sequencing (WGS), and a further 266 samples by targeted sequencing. The subtypes were 136 intrahepatic cholangiocarcinomas (ICCs), 101 distal cholangiocarcinomas (DCCs), 109 peri-hilar type cholangiocarcinomas (PHCs), and 66 gallbladder or cystic duct cancers (GBCs/CDCs). We identified somatic alterations and searched for driver genes in BTCs, finding pathogenic germline variants of cancer-predisposing genes. We predicted cell-of-origin for BTCs by combining somatic mutation patterns and epigenetic features.RESULTS:We identified 32 significantly and commonly mutated genes including TP53, KRAS, SMAD4, NF1, ARID1A, PBRM1, and ATR, some of which negatively affected patient prognosis. A novel deletion of MUC17 at 7q22.1 affected patient prognosis. Cell-of-origin predictions using WGS and epigenetic features suggest hepatocyte-origin of hepatitis-related ICCs. Deleterious germline mutations of cancer-predisposing genes such as BRCA1, BRCA2, RAD51D, MLH1, or MSH2 were detected in 11% (16/146) of BTC patients.CONCLUSIONS:BTCs have distinct genetic features including somatic events and germline predisposition. These findings could be useful to establish treatment and diagnostic strategies for BTCs based on genetic information.LAY SUMMARY:We here analyzed genomic features of 412 BTC samples from Japanese and Italian populations. A total of 32 significantly and commonly mutated genes were identified, some of which negatively affected patient prognosis, i |
| DOI | 10.1016/j.jhep.2018.01.009 |
| PMID | 29360550 |